8-K: Fractyl Health Faces Nasdaq Delisting Threat

Fractyl Health, Inc. received a notice from Nasdaq indicating its common stock is subject to delisting unless a hearing is requested, due to a sustained low bid price.

Summary

• Fractyl Health, Inc. was notified by Nasdaq on September 10, 2026, that its common stock is subject to delisting.
• This notification follows a failure to meet the Minimum Bid Price Requirement, where the stock's price has been below $1.00 for 30 consecutive business days.
• The company did not regain compliance within the 180-day grace period ending September 9, 2026.
• Fractyl Health intends to request a hearing before a Nasdaq Hearings Panel to contest the delisting.
• A hearing request will stay any suspension or delisting, allowing the stock to trade on Nasdaq pending the outcome.
• To regain compliance, the stock must maintain a minimum bid price of at least $1.00 for 10 to 20 consecutive business days.
• The company previously filed a proxy statement on August 24, 2026, seeking shareholder approval for a reverse stock split (1-for-5 to 1-for-15) to address the bid price issue.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the impending delisting threat, although the company plans to contest it.

Positives

• The company intends to request a hearing, which will automatically stay the delisting process.
• Fractyl Health expects its common stock to continue trading on Nasdaq while the hearing process concludes.
• A reverse stock split proposal is being considered by shareholders, which could help regain compliance.

Negatives

• The company's common stock is subject to delisting from the Nasdaq Global Market.
• The stock has failed to meet the Minimum Bid Price Requirement of $1.00 for 30 consecutive business days.
• The company did not regain compliance within the 180-day grace period provided by Nasdaq.

Risks

• Failure to regain compliance with the Minimum Bid Price Requirement after the hearing process.
• Potential negative impact on investor confidence and stock liquidity due to the delisting threat.
• The effectiveness of a reverse stock split in maintaining a bid price above $1.00 long-term.

Future Outlook

The company expects its common stock to continue trading on Nasdaq pending the conclusion of the hearings process, contingent on requesting a hearing and potentially regaining compliance through a reverse stock split or sustained price improvement.

Management Comments

• The Company intends to timely request a hearing before the Panel.
• The Company expects that its common stock will continue to be listed and traded on Nasdaq pending the conclusion of the hearings process.

Industry Context

StockSavvy.ai notes that Nasdaq delisting notices due to low bid prices are not uncommon, especially for smaller or growth-stage companies. Companies often resort to reverse stock splits to artificially inflate their share price and avoid delisting, though this can sometimes be viewed negatively by the market.

Stakeholder Impact

• Shareholders: Potential for increased volatility and uncertainty regarding the stock's listing status. A reverse stock split could reduce the number of shares outstanding, potentially impacting per-share metrics.
• Investors: May face reduced liquidity if the stock is delisted. The threat of delisting can deter new investment.

Next Steps

• Request a hearing before the Nasdaq Hearings Panel.
• Seek shareholder approval for a reverse stock split (if not already obtained).
• Work to regain compliance with the Minimum Bid Price Requirement (at least $1.00 for 10-20 consecutive business days).

Key Dates

Recommendation

The immediate threat of delisting is a significant negative. However, the company's intent to contest the delisting and its prior action to seek shareholder approval for a reverse stock split suggest a proactive approach. A 'hold' recommendation reflects the uncertainty and the need to await the outcome of the hearing and potential corporate actions, while acknowledging the company's efforts to remain listed.

Keywords

delisting, Nasdaq, minimum bid price, reverse stock split, compliance, hearing panel, stockholder approval